Henry Mayo Newhall Memorial Hospital to Proceed With Master Plan
VALENCIA, Calif., Nov. 25 /PRNewswire/ -- Henry Mayo Newhall Memorial Hospital in Valencia, California, has received approval from the local City Council to proceed with its $300 million master plan. The plan calls for the development of a new patient wing and three new medical buildings, plus a h...Bradmer receives FDA approval to proceed with Phase III clinical trial
Clinical and Manufacturing Plans Approved for Neuradiab(TM) Multi- center Clinical Trial TSX: BMR TORONTO, June 3 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commer...VNUS Medical's Patent Lawsuit Against Laser Competitors to Proceed to Trial
SAN JOSE, Calif., Oct. 3 /PRNewswire-FirstCall/ -- The patent lawsuit by VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS ) against three endovenous laser competitors, Diomed, AngioDynamics and Vascular Solutions, is set to proceed to trial after the court's denial of summary judgment motions...Sunrise Reports Financial Results for Second-Quarter 2009
...s, although there can be no assurance that the initial bids received will result in the consummation of a sale. If a sale does not occur, Sunrise will proceed with closing the communities and negotiating a settlement with the lenders. Based on the bids the Company has received, Sunrise determined that the bo...Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
...d development programs; results of clinical trials or preclinical studies may not be predictive of future results; clinical trials and studies may not proceed at the time or in the manner Arena expects or at all; Arena's ability to partner lorcaserin or other of its compounds or programs; the timing and abil...Unlocking the key to human fertility
...think it may also be ancient in origin." Without the right 'key', successful fertilisation either cannot occur, or if it does, development will not proceed normally. Notably, disturbances in human sperm DNA packaging are known to cause male infertility and pregnancy failures. This 'lock and key' mecha...R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
...ur self-developed RK-023 that focuses on the dermatology field. We intend to start a phase 2 clinical study in Japan as scheduled and at the same time proceed with full-scale negotiations for partnership at home and abroad." Having obtained the results of the above-mentioned phase 1 clinical study, ...Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
...ile the sections of the NDA as they become available instead of filing all the sections at once. It also enables the agency to commence its review and proceed on a rolling basis as the additional sections are completed and submitted for review. Shire is completing a phase III clinical program that inc...CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
...volve known and unknown risks, uncertainties and other factors including the risk that any one or more of CuraGen's drug development programs will not proceed as planned for technical, scientific or commercial reasons or due to patient enrollment issues or based on new information from nonclinical or clinica...Neurocrine Biosciences Presents Elagolix Data
...o, risk that the Company's elagolix Phase II clinical trials will fail to demonstrate that elagolix is safe and effective; risk that elagolix will not proceed to later stage clinical trials; risk associated with the Company's dependence on corporate collaborators for development, commercial manufacturing and...Attain Prevail™ Steerable Catheter Left-Heart Lead Delivery System
Description:...or fixedshape guide catheter. Attain Prevail provides for additional telescoping with a guide wire. Subselection - Advance into the coronary sinus and proceed with vein subselection with the guide wire and the Attain Prevail's atraumatic tip. Open lumen allows for the deep seating of various guide wires and,...Canadian researchers set to study impact of nanomaterials on aquatic ecosystems
...aid Greg Goss, project co-leader and professor of biological sciences, University of Alberta. "This research will allow the nanotechnology industry to proceed with confidence [in the knowledge] that the environmental safety of their products can be properly assessed. In addition, the companies can use the kn...The SIB recognizes the next generation of bioinformaticians
...specifically on how the timing of expression in development affects selective pressure on genes. In his own words: "Because embryonic development must proceed correctly for an animal to survive, changes in evolution are constrained according to their effects on development. Changes that disrupt development t...Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics
...le technology. A trace is swept horizontally across the screen, but instead of deflecting the beam up and down, the beam is interrupted or allowed to proceed toward the phosphor screen, where the trace shows up as a bright or dark spot. The display is then scanned across the screen again in a raster pattern...HIV pays a price for invisibility
...-mutated virus came out on top despite its reduced replication. In these individuals, the avoidance of killer T cells allowed the infection to rapidly proceed to clinical illness. This study suggests that vaccines should be designed to produce a T cell response against a number of different viral peptides s...SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
TSX symbol: SBS CALGARY, Sept. 16 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that it is eligible to proceed with its planned Phase I/II human cli...Avicena's HD-02 to Proceed to NIH Sponsored Phase III Huntington's Disease Trial
PALO ALTO, Calif., March 12 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today that it met with the Food and Drug Administration (FDA) and...Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
DEERFIELD, Ill., Feb. 28 /PRNewswire-FirstCall/ -- Baxter International Inc. announced today that the company is proceeding with the voluntary recall of all remaining lots and doses of its heparin sodium injection multi-dose, single-dose vials and HEP-LOCK heparin flush products. The company...Audit of multi-million dollar state IT spending will proceed
Madison, Wis. The Joint Legislative Audit Committee voted unanimously to authorize an audit of troubled information technology system projects in state agencies. The 6-0 vote came after several hours of testimony on Wednesday from state auditors and agency personnel confirmed the state has lo...InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
...may be made which may lead to material change in the company's current regulatory strategy for pirfenidone, including a decision by the company not to proceed with either or both of its regulatory submissions in the United States and Europe. These analyses and observations are expected to be included in one ...CuraGen Reports Second Quarter 2009 Financial Results
...her than anticipated legal and advisory fees and a delay in the closing of the merger; any one or more of CuraGen's drug development programs will not proceed as planned for technical, scientific or commercial reasons or due to patient enrollment issues or based on new information from nonclinical or clinica...CpG WIZ® DAP-KINASE AMPLIFICATION KIT from CHEMICON
Description:...eal to any DNA (unmethylated or methylated) that has NOT undergone chemical modification, hence, the "wild type", or W. Data interpretation can still proceed in the case of incomplete chemical modification (up to 50%). The amplified region is defined as the sequence between the 3' nucleotide of the sense pr...Hybridoma Development from QED Bioscience Inc.
Description:...ed until directed otherwise by the client. Development is set up in phases. Billing is at the beginning of each phase, so if the project does not proceed to the subsequent phase, you are not billed. PHASE I: IMMUNIZATION 1. Immunization of 5 Balb/c mice. 2. Initial rest period of 8 week...